Ascendis Pharma A (ASND) EBIT Margin (QoQ) (2014 - 2026)
Ascendis Pharma A (ASND) EBIT Margin (QoQ) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Ascendis Pharma A |
2.75 Bn |
2.08 Bn |
268.20 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
703.00 |
| Dec 31, 2025 |
-212.00 |
| Sep 30, 2025 |
3,865.00 |
| Jun 30, 2025 |
6,972.00 |
| Mar 31, 2025 |
-15.18 Mn |
| Dec 31, 2024 |
15.19 Mn |
| Sep 30, 2024 |
20,290.00 |
| Jun 30, 2024 |
-31,893.00 |
| Mar 31, 2024 |
-3,618.00 |
| Dec 31, 2023 |
26,475.00 |
| Sep 30, 2023 |
1,735.00 |
| Jun 30, 2023 |
13,060.00 |
| Mar 31, 2023 |
21,598.00 |
| Dec 31, 2022 |
30,134.00 |
| Sep 30, 2022 |
135,836.00 |
| Jun 30, 2022 |
-42,840.00 |
| Mar 31, 2022 |
-172,994.00 |
| Dec 31, 2021 |
856,396.00 |
| Sep 30, 2021 |
280,061.00 |
| Jun 30, 2021 |
519,943.00 |
